Ginkgo Bioworks funds Access Bio's rapid antigen test manufacturing expansion in New Jersey

Ginkgo Bioworks provided capital to expand manufacturing capacity at Access Bio's New Jersey factory for production of rapid diagnostic tests, and secured access to at least 10 million rapid antigen test kits.

“Ginkgo provided capital to expand manufacturing capacity at Access Bio's New Jersey factory for production of rapid diagnostic tests.”biospace.com

• 1 source
• biospace.comGinkgo Bioworks Funds Expansion of Rapid Antigen Test Manufacturing with Access Bio in New Jersey - BioSpaceHeather McKenzieNov 20, 2020

Summarized from public sources; check the original articles before acting on it.